Quinlan Paul T sold ORKA
October 20, 2026 · Form 4 insider transaction
Quinlan Paul T sold 500 shares of Oruka Therapeutics, Inc. at $76.12 per share, a transaction worth $38.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
500
Price
$76.12
Total value
$38.1K
InsiderQuinlan Paul T
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 20, 2026
Filing dateOctober 20, 2026
Shares owned after38,095
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.61 to $76.42, inclusive.